Dong-Sheng Chen
Overview
Explore the profile of Dong-Sheng Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
158
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Ma P, Shen H, Chen D, Lu Z, Gao W, Shu Y
Oral Oncol
. 2022 May;
130:105905.
PMID: 35594774
No abstract available.
12.
Wei Q, Chen D, Liu Y
Front Oncol
. 2022 Apr;
12:853211.
PMID: 35359396
Niraparib, an oral, potent, highly selective poly (ADP-ribose) polymerase (PARP) inhibitor, has promising clinical benefit for maintenance treatment of patients with ovarian cancer in partial response to platinum-based chemotherapy, especially...
13.
Chen A, Chen D, Li S, Zhao L, Xiao M
Front Oncol
. 2022 Mar;
12:837219.
PMID: 35299735
Novel adjuvant strategies are needed to optimize outcomes after complete surgical resection in patients with early-stage non-small-cell lung cancer (NSCLC). The adjuvant treatment of ROS Proto-Oncogene 1 () fusion-positive resected...
14.
Zhu J, Chen D, Ma Y, Chen M, Yang Y
Eur J Cancer
. 2022 Jan;
163:77-78.
PMID: 35033995
No abstract available.
15.
Chen H, Gong X, Li W, Chen D, Zhao L, Li S, et al.
Oral Oncol
. 2021 Aug;
121:105436.
PMID: 34371452
Background: Sarcomatoid carcinoma (SC) of the head and neck (HN) is a rare disease that has both sarcomatoid and cancerous components. The genetic background and mechanisms of tumorigenesis remain largely...
16.
Zhang M, Chen D, Li S, Chen L, Qi Y, Zhang C
Invest New Drugs
. 2021 Apr;
39(5):1436-1438.
PMID: 33913072
Gastric cancer (GC) has the third highest rate of cancer incidence and mortality worldwide. First-line immune checkpoint inhibitor (ICI) therapy for advanced GC led to landmark breakthroughs, but which GC...
17.
Jin L, Wu Z, Wang Y, Chen D, Li S, Xiao M, et al.
Invest New Drugs
. 2021 Apr;
39(5):1419-1421.
PMID: 33835358
Compound epidermal growth factor receptor (EGFR) mutations are defined as double or multiple independent mutations of the EGFR tyrosine kinase domain (TKD), in which an EGFR-tyrosine kinase inhibitor (TKI)-sensitizing mutation...
18.
Wang Y, Wu Z, Zhang H, Chen D, Zhao X
Lung Cancer
. 2021 Feb;
154:216-218.
PMID: 33637344
No abstract available.
19.
Ma H, Chen D, Li S, Xiao M, Qi C
Oral Oncol
. 2021 Jan;
117:105179.
PMID: 33514453
No abstract available.
20.
Zhao Y, Yin J, Wu H, Ding T, Wang Y, Liang J, et al.
Pain Physician
. 2018 Oct;
21(5):E555-E564.
PMID: 30282403
Background: Over-expression of spinal protein kinase Cγ(PKCγ) contributes to the induction of persistent bilateral hyperalgesia following inflammatory injury, yet the role of spinal PKCγ in short- and long-lasting pain behavior...